Experience

OCT is a leading CRO operating in Russia, Central and Eastern Europe and the US. With the team of more than 90 professionals, OCT provides a full range of high-quality services within Phase I to IV including the organization and conduct of BE studies.

With local expertise in the countries of our operations and a focus on quality, we ensure that the Sponsor’s product advances through clinical development and approval on time and within budget. Our experienced team delivers quality results for our clients' development needs from standalone CRO services such as medical writing, consultancy, project management/monitoring, data management / statistics to the management and conduct of full clinical programs.

Since 2005 OCT has been involved in more than 150 full-service and functional service projects in a number of therapeutic areas.

Please see below a breakdown of OCT’s experience by year, therapeutic area and phase:

Osteoarthritis
Therapeutic area:  Rheumatology
Phase:  III
Year:  2017

Ulcerative Colitis
Therapeutic area:  Gastroenterology
Phase:  I
Year:  2017

Type I Diabetes Mellitus
Therapeutic area:  Endocrinology
Phase:  n/a
Year:  2017

Acute diarrhea
Therapeutic area:  Pediatrics
Phase:  III
Year:  2017

Flu vaccine
Therapeutic area:  Infectious diseases
Phase:  I
Year:  2017

Chronic cerebral ischemia
Therapeutic area:  Neurology
Phase:  n/a
Year:  2017

Pain
Therapeutic area:  Neurology
Phase:  III
Year:  2017

Seborrheic dermatitis
Therapeutic area:  Dermatology
Phase:  III
Year:  2017

Flu vaccine
Therapeutic area:  Infectious diseases
Phase:  III
Year:  2017

Breast Cancer
Therapeutic area:  Oncology
Phase:  n/a
Year:  2017

Parenteral Feeding
Therapeutic area:  Surgery
Phase:  III
Year:  2017

Lower limb ischemia
Therapeutic area:  Vascular
Phase:  II
Year:  2017

Tuberculosis
Therapeutic area:  Infectious diseases
Phase:  II
Year:  2017

Flu vaccine
Therapeutic area:  Respiratory diseases
Phase:  I
Year:  2017

HIV
Therapeutic area:  Infectious diseases
Phase:  BE study
Year:  2017

Hematology oncology
Therapeutic area:  Oncology
Phase:  II
Year:  2017

Osteoarthrosis
Therapeutic area:  Internal diseases
Phase:  IV
Year:  2017

Hematology oncology
Therapeutic area:  Oncology
Phase:  II
Year:  2017

Hematology oncology
Therapeutic area:  Oncology
Phase:  II
Year:  2017

Astenospermia
Therapeutic area:  Urology
Phase:  II
Year:  2017


Новости 1 - 20 of 254

Detailed study list see below: